Psychology

sort by:

Effect of varenicline and placebo on PANSS Total and Depression Scores.

Effect of varenicline and placebo on PANSS Total and Depression Scores.

figure posted on 2016-01-18

Comparison of MATRICS Battery Domain and Overall Composite Scores In varenicline- and placebo- treated patients.

Comparison of MATRICS Battery Domain and Overall Composite Scores In varenicline- and placebo- treated patients.

figure posted on 2016-01-18

Flow chart of disposition of patients through the study.

Flow chart of disposition of patients through the study.

figure posted on 2016-01-18

Effects of varenicline and placebo on measures related to cigarette smoking.

Effects of varenicline and placebo on measures related to cigarette smoking.

figure posted on 2016-01-18

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial

dataset posted on 2016-01-18

Subject characteristics in varenicline and placebo groups.

dataset posted on 2016-01-05

Change from baseline in smoking related measures at selected weeks of treatment after baseline.

dataset posted on 2016-01-05

Change from baseline in MATRICS Battery Scores by week 8 of drug treatment.

dataset posted on 2016-01-05

Change from baseline in psychiatric symptoms scores with varenicline or placebo.

dataset posted on 2016-01-05

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways

dataset posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 1

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 1

figure posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 2

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 2

figure posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 3

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 3

figure posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 4

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 4

figure posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 5

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 5

figure posted on 2015-05-08

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 6

Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-β1 Induced Non-Smad Pathways - Fig 6

figure posted on 2015-05-08

TGF-β1 increases SERT levels on the luminal surface in 3D-culture of Caco-2 cells.

TGF-β1 increases SERT levels on the luminal surface in 3D-culture of Caco-2 cells.

figure posted on 2015-05-08

SERT function in response to TGF-β1 treatment of native mouse ileum.

SERT function in response to TGF-β1 treatment of native mouse ileum.

figure posted on 2015-05-08

CNV Analysis in Tourette Syndrome Implicates Large Genomic Rearrangements in <em>COL8A1</em> and <em>NRXN1</em>

CNV Analysis in Tourette Syndrome Implicates Large Genomic Rearrangements in COL8A1 and NRXN1

dataset posted on 2013-03-23

Number of TS cases and controls with CNVs affecting COL8A1 and NRXN1 detected using SNP-based calls, MLPA or both.

dataset posted on 2013-03-22

CNV burden in TS cases and controls.

dataset posted on 2013-03-22

Chromosomal regions harbouring large (>500 kb) CNVs overlapping annotated gene exons in at least two TS cases and not in controls.

dataset posted on 2013-03-22

Regions harbouring smaller CNVs (<500 kb) overlapping gene exons in at least two TS cases but not in controls.

dataset posted on 2013-03-22

Basal OT is significantly correlated to Principal Component (PC) 1 (r = −0.62, p = 0.04, Spearman’s rho) and PC2 (r = 0.85, p = 0.0008, Spearman’s rho) of three social behavioral measurements in WS cohort (n = 11).

dataset posted on 2012-06-12

Analyses of longitudinal changes in OT and AVP based on raw and log transformed data. *P<0.05, **P<0.005.

dataset posted on 2012-06-12

Correlations of peak responses to music and cold for OT and AVP show different patterns in WS versus TC.

Correlations of peak responses to music and cold for OT and AVP show different patterns in WS versus TC.

figure posted on 2012-06-12

Responses of OT and AVP to music and of OT to cold, are greater and more variable in WS than in TC.

Responses of OT and AVP to music and of OT to cold, are greater and more variable in WS than in TC.

figure posted on 2012-06-12

Differences in longitudinal OT and AVP levels for the combined WS versus TC cohorts shown on a common scale without the logarithmic transformation.

Differences in longitudinal OT and AVP levels for the combined WS versus TC cohorts shown on a common scale without the logarithmic transformation.

figure posted on 2012-06-12

OT levels (pg/mL) measured by enzyme immunoassay in WS cohort are significantly higher than the TC cohort at all ten time points.

OT levels (pg/mL) measured by enzyme immunoassay in WS cohort are significantly higher than the TC cohort at all ten time points.

figure posted on 2012-06-12

Comparison of basal neuropeptide levels in WS versus TC on the logarithmic scale.

Comparison of basal neuropeptide levels in WS versus TC on the logarithmic scale.

figure posted on 2012-06-12

Experimental paradigm used to test neuropeptide and autonomic responses to stimuli in WS and TC.

Experimental paradigm used to test neuropeptide and autonomic responses to stimuli in WS and TC.

figure posted on 2012-06-12

Oxytocin and Vasopressin Are Dysregulated in Williams Syndrome, a Genetic Disorder Affecting Social Behavior

Oxytocin and Vasopressin Are Dysregulated in Williams Syndrome, a Genetic Disorder Affecting Social Behavior

dataset posted on 2012-06-12

Antibodies used for immunocytochemistry, immunofluorescence and western blotting.

dataset posted on 2012-05-02

Material examined, cause of death, and the prevalence of epilepsy.

dataset posted on 2012-05-02

Detection by Western blots of Aβ in plaque-free subjects.

Detection by Western blots of Aβ in plaque-free subjects.

figure posted on 2012-05-02

Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders

Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders

dataset posted on 2012-05-02

Properties of Aβ in plaque-rich cortex characterized by Western blotting.

Properties of Aβ in plaque-rich cortex characterized by Western blotting.

figure posted on 2012-05-02

Full-length Aβ in diffuse plaques, and truncated Aβ in astrocytes in idiopathic autism.

Full-length Aβ in diffuse plaques, and truncated Aβ in astrocytes in idiopathic autism.

figure posted on 2012-05-02

Full-length Aβ in diffuse plaques and amino-terminally truncated Aβ in astrocytes in autism/dup15.

Full-length Aβ in diffuse plaques and amino-terminally truncated Aβ in astrocytes in autism/dup15.

figure posted on 2012-05-02

Immunoreactivity of mAb 4G8 with Aβ.

Immunoreactivity of mAb 4G8 with Aβ.

figure posted on 2012-05-02